Abstract
The crude polysaccharide (SCP) extracted from Schisandra chinensis by hot water extraction and ethanol precipitation, was further fractionated by DEAE-cellulose and Sephacryl S-300 chromatography, giving a polysaccharide fraction named as SCP-BII. The molecular weight of SCP-BII was 23 kDa using HPGPC. Gas chromatography analysis suggested that SCP-BII was composed of rhamnose, arabinose, mannose, galactose, glucose and galacturonic acid with a ratio of 4.7:2.6:0.8:5.6:1:5.6. Pharmaceutical experiments showed SCP-BII administered in alloxan-induced diabetic mice can significantly reduce blood glucose levels and water intake, and increase the body weight of diabetic mice. The results suggest SCP-BII attenuated the diabetes-induced weight loss, polydipsia and hyperglycemia, and these improvements suggest that Schisandra chinensis could be considered as a potential anti-diabetic agent.
Keywords: Schisandra chinensis, polysaccharide, purification, hypoglycemic, alloxan, anti-diabetic agent
Letters in Organic Chemistry
Title: Isolation, Characterization and Hypoglycemic Activity of an Acid Polysaccharide Isolated from Schisandra chinensis (Turcz.) Baill
Volume: 6 Issue: 5
Author(s): Xiaoxv Gao, Xianjun Meng, Jihai Li and Haibin Tong
Affiliation:
Keywords: Schisandra chinensis, polysaccharide, purification, hypoglycemic, alloxan, anti-diabetic agent
Abstract: The crude polysaccharide (SCP) extracted from Schisandra chinensis by hot water extraction and ethanol precipitation, was further fractionated by DEAE-cellulose and Sephacryl S-300 chromatography, giving a polysaccharide fraction named as SCP-BII. The molecular weight of SCP-BII was 23 kDa using HPGPC. Gas chromatography analysis suggested that SCP-BII was composed of rhamnose, arabinose, mannose, galactose, glucose and galacturonic acid with a ratio of 4.7:2.6:0.8:5.6:1:5.6. Pharmaceutical experiments showed SCP-BII administered in alloxan-induced diabetic mice can significantly reduce blood glucose levels and water intake, and increase the body weight of diabetic mice. The results suggest SCP-BII attenuated the diabetes-induced weight loss, polydipsia and hyperglycemia, and these improvements suggest that Schisandra chinensis could be considered as a potential anti-diabetic agent.
Export Options
About this article
Cite this article as:
Gao Xiaoxv, Meng Xianjun, Li Jihai and Tong Haibin, Isolation, Characterization and Hypoglycemic Activity of an Acid Polysaccharide Isolated from Schisandra chinensis (Turcz.) Baill, Letters in Organic Chemistry 2009; 6 (5) . https://dx.doi.org/10.2174/157017809788681374
DOI https://dx.doi.org/10.2174/157017809788681374 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Impact of Hyperhomocyst(e)inemia on Endothelial Function
Vascular Disease Prevention (Discontinued) Antioxidant Therapy in Diabetic Complications: What is New?
Current Vascular Pharmacology How Drugs Influencing Central Blood Pressure Prevent Atherosclerosis Complications?
Current Pharmaceutical Biotechnology Pathogenesis and Treatment of Type 2 Diabetic Nephropathy: Lessons from the Spontaneous KK/Ta Mouse Model
Current Diabetes Reviews Design and Evaluation of Transdermal Patches of Timolol Maleate
Current Drug Delivery Is Impaired Flow-Mediated Dilatation of the Brachial Artery a Cardiovascular Risk Factor?
Current Vascular Pharmacology Trends in Metabolic Syndrome and Gene Networks in Human and Rodent Models
Endocrine, Metabolic & Immune Disorders - Drug Targets Mechanisms and Drug Targets for Pancreatic Cancer Chemoprevention
Current Medicinal Chemistry Vascularization of Biomaterials for Bone Tissue Engineering: Current Approaches and Major Challenges
Current Angiogenesis (Discontinued) The Angiotensin Converting Enzyme 2 (ACE2), Gut Microbiota, and Cardiovascular Health
Protein & Peptide Letters NOS: Molecular Mechanisms, Clinical Aspects, Therapeutic and Monitoring Approaches
Current Drug Targets - Inflammation & Allergy Tyrosine Kinase Inhibitors for the Treatment of Rheumatoid Arthritis
Current Topics in Medicinal Chemistry Cardiac Stem Cell Characteristics in Physiological and Pathological Conditions
Current Pharmaceutical Design Cardiac Autonomic Nervous System in Heart Failure: Imaging Technique and Clinical Implications
Current Cardiology Reviews Antihyperglycemic Effect of the Moroccan Collard Green (<i>Brassica oleracea</i> var. <i>viridis</i>) in Streptozotocin-Induced Diabetic Rats
Endocrine, Metabolic & Immune Disorders - Drug Targets Transient Tachypnea of the Newborn: The Treatment Strategies
Current Pharmaceutical Design The Role of Apelins in the Physiology of the Heart
Protein & Peptide Letters Novel Biomarkers Assessing Renal Function in Heart Failure: Relation to Inflammatory Status and Cardiac Remodelling
Current Medicinal Chemistry Novel Diagnostics R&D for Public Health and Personalized Medicine in Taiwan: Current State, Challenges and Opportunities
Current Pharmacogenomics and Personalized Medicine Pharmacophore and 3D QSAR Study of TGFβ Inhibitors
Letters in Drug Design & Discovery